Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nataki Douglas

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Obstetrics and Gynecology|September 19, 2019
Undetectable equals untransmittable (U = U): implications for preconception counseling for human immunodeficiency virus serodiscordant couplesShweta J Bhatt, Nataki Douglas
Obstetrics and Gynecology|July 27, 2019
In ReplyErin Burke, Safedin Beqaj, Nataki Douglas
Biology of Reproduction|March 13, 2026
Role of KIT signaling in ovarian development and function: Insights from multisystem biologyWonmi So, Ashley E Pak, Amirhossein Abazarikia, et al.
Cancer|February 27, 2010
Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapyBo Yu, Nataki Douglas, Michel J Ferin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Obstetrics and Gynecology|September 19, 2019
Undetectable equals untransmittable (U = U): implications for preconception counseling for human immunodeficiency virus serodiscordant couplesShweta J Bhatt, Nataki Douglas
Obstetrics and Gynecology|July 27, 2019
In ReplyErin Burke, Safedin Beqaj, Nataki Douglas
Biology of Reproduction|March 13, 2026
Role of KIT signaling in ovarian development and function: Insights from multisystem biologyWonmi So, Ashley E Pak, Amirhossein Abazarikia, et al.
Cancer|February 27, 2010
Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapyBo Yu, Nataki Douglas, Michel J Ferin, et al.
Pageof 1